Karen Bergman | VP, IR & Corporate Communications |
Thomas Neff | Founder, Chairman and Chief Executive Officer |
Peony Yu | Chief Medical Officer |
Christine Chung | VP China Operations |
Elias Kouchakji | VP, Clinical Development, Drug Safety & Pharmacovigilance |
Pat Cotroneo | Chief Financial Officer |
Difei Yang | Mizuho Securities |
Gavin Parsons | Goldman Sachs |
Geoffrey Porges | Leerink Partners |
Joel Beatty | Citigroup |
Michael Yee | Jefferies |
Andrew Tsai | William Blair |
Hello and welcome to FibroGen Third Quarter 2018 Financial Results Teleconference Call. My name is Michelle, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session [Operator Instructions]. Please note that this conference is being recorded.